Latest

We are proud to announce the release of the EASL Guidelines App 2.0 – a powerful upgrade of the essential mobile resource for healthcare professionals in hepatology. Designed to deliver quick, easy, and…

This ambitious collaboration between academic, clinical, and industry partners aims to transform how liver diseases are diagnosed and treated by developing innovative and cost-effective tools for early diagnosis and personalized care, with…

The ambition of the LiverScreen Consortium has been realised with the screening of more than 30.000 participants from the general population across 9 different European Countries and the development & validation of…

DECISION strives to better understand the pathophysiology of decompensated cirrhosis leading to acute-on-chronic liver failure (ACLF) at the systems level by taking advantage of already existing large and clinically well-characterized patient cohorts.…

22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease (cirrhosis). We aim to identify microbiome-based biomarkers and mechanisms that predict in advance when the…

A-TANGO strives to increase the survival rate with G-TAK – a novel combinatorial therapy, and to decrease the burden on the national healthcare systems, which is caused by a large percentage of patients…

For immediate release  (Geneva, 10 April 2025) The European Association for the Study of the Liver (EASL) is calling on Taoiseach Micheál Martin to reaffirm Ireland’s commitment to its world-leading alcohol labelling…